Breaking News, Financial News

Financial Report: BASi

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi 3Q Revenues: $12.6 million (26%) 3Q Earnings: $449,000 (loss of $1.8 million 3Q2006) YTD Revenues: $34.8 million (+8%) YTD Earnings: $1.1 million (loss of $1.9 million YTD2006) Comments: Revenue growth was driven by a $2.7 million, or 34%, increase in service revenues, led by improvements in toxicology and clinical research operations. YTD growth was the result of a 10% increase in service revenues. Operating expenses in the quarter were $3 million, a decrease of $1.9...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters